医务专员 at Acadia Pharmaceuticals

Shanghai, Shanghai, China

Apply Now

Not SpecifiedCompensation

Junior (1 to 2 years), Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

PharmaceuticalsIndustries

Requirements

医学、药学、护理、医药市场营销等相关专业本科或以上学历。
至少1年的医药销售相关经验（高级医务代表3-5年相关经验，医务专员5年以上）。
有一定的英语及计算机操作技能。
与客户建立良好关系、培养潜在客户及开发新客户的能力。
积极主动、外向热情、具备良好的沟通技能能力。
以客户为中心、行动导向、毅力、计划性、专业技能学习、追求成效、道德与价值观。

Responsibilities

负责在市场上推广和介绍公司产品。
完成分配的销售任务。
拜访目标医院，了解医生对公司产品的看法。
建立与更新客户档案，与客户保持良好关系。
掌握市场动态，及时反馈客户关于市场趋势及产品和竞品之信息。
协助组织产品研讨会。
与现有客户保持良好关系，发展潜力客户。

Skills

Key technologies and capabilities for this role

Pharmaceutical SalesCustomer Relationship ManagementMarket AnalysisSales PromotionProduct SeminarsEnglish ProficiencyComputer SkillsCommunication Skills

Questions & Answers

Common questions about this position

What experience is required for the Medical Representative positions?

At least 1 year of pharmaceutical sales related experience is required (3-5 years for senior representative, 5+ years for specialist).

What educational background is needed for this role?

A bachelor's degree or above in medicine, pharmacy, nursing, pharmaceutical marketing or related majors is required.

What is the location for this position?

The location is Ferring China M&S.

What salary or compensation does this role offer?

This information is not specified in the job description.

What personal qualities make a strong candidate for this position?

Candidates should be proactive, outgoing, enthusiastic, with good communication skills, customer-centered, action-oriented, perseverant, planned, professional in learning skills, results-driven, and strong in morals and values.

Acadia Pharmaceuticals

Develops therapies for neurological disorders

About Acadia Pharmaceuticals

Acadia Pharmaceuticals develops therapies for neurological disorders, focusing on conditions like Parkinson's disease, schizophrenia, and Rett syndrome. The company conducts extensive research and clinical trials to create drugs that are safe and effective, seeking approval from regulatory bodies like the FDA before bringing them to market. Acadia differentiates itself by targeting areas with significant unmet medical needs, ensuring that their products address critical health challenges. Their goal is to improve the quality of life for patients suffering from these disorders while also promoting diversity, equity, and inclusion within their operations.

Dallas, TexasHeadquarters

1993Year Founded

$813.4MTotal Funding

ACQUISITIONCompany Stage

Biotechnology, HealthcareIndustries

501-1,000Employees

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

401(k) Company Match

Employee Stock Purchase Plan

Paid Vacation

Paid Holidays

Paid Sick Leave

Paid Parental Leave

Tuition Reimbursement

Risks

Increased competition in CNS drug market may impact Acadia's market share.

Potential clinical trial delays could affect drug approval timelines.

Dependence on partnerships poses risks if collaborations face challenges or dissolve.

Differentiation

Acadia focuses on CNS disorders with unmet medical needs, like Parkinson's and Rett syndrome.

The company has a strong R&D foundation, developing innovative small molecule drugs.

Acadia's strategic partnerships enhance its research capabilities and market reach.

Upsides

Acadia's collaboration with Saniona expands its portfolio with SAN711 for neurological disorders.

Health Canada's approval of Daybue boosts Acadia's presence in the Canadian market.

The rise of personalized medicine aligns with Acadia's targeted therapy approach.

Land your dream remote job 3x faster with AI

Try Jobo Free